The specific dependence of CRC risk-associated trans-eQTL target homolog expression on Pou2af2 implies (i) 11q23.1 variation may confer CRC risk via dysregulation of this gene specifically and (ii) causal relevance of associated tuft cell abundance changes. Here, POU2AF2 is linked to colorectal carcinoma.